SITE009-0268

SITE009 (AUS) › SITE009-0268

SITE009-0268

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2026-07-24

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-03-03 (study day 38); relationship: not assessed

mild assessed

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-02-01 (study day 8); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.